Campbell Le Heron
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Campbell Le Heron has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
- Daniel J. Myall
New Zealand Brain Research Institute Christchurch New Zealand
8 shared publications - Michael R. MacAskill
New Zealand Brain Research Institute Christchurch New Zealand
6 shared publications - Tim J. Anderson
New Zealand Brain Research Institute Christchurch New Zealand
6 shared publications - John C. Dalrymple-Alford
Te Kura Mahi ā‐Hirikapo School of Psychology, Speech and Hearing University of Canterbury Christchurch New Zealand
5 shared publications - Toni L. Pitcher
New Zealand Brain Research Institute Christchurch New Zealand
5 shared publications - Tracy R. Melzer
Te Kura Mahi ā‐Hirikapo, School of Psychology, Speech and Hearing University of Canterbury Christchurch New Zealand
5 shared publications
Latest Publications
- Open Access
- 19 October 2026
- Published by Wiley in Movement Disorders
Cortical Cholinergic Pathway Degeneration Reflects Cognitive Impairment and Dementia in Parkinson's Disease
Background: Cognitive impairment is a prevalent and debilitating feature of Parkinson's disease (PD). Increasing evidence from postmortem and in vivo positron emission tomography imaging studies supports cholinergic dysfunction in PD. There is, however, little evidence regarding the influence of the structural integrity of cortical cholinergic pathways that emanate from the nucleus basalis of Meynert (NBM). Objectives: To investigate the association between cognition and the structural integrity of medial and lateral cortical cholinergic projection pathways in PD. Methods: Neuropsychological assessment, T1 imaging, and high angular resolution diffusion imaging (HARDI) were acquired from 108 participants with PD (41 female, mean age 71.3 years) and 41 control participants (22 female, mean age 70.6 years). Streamlines representing three cortical cholinergic pathways (one medial and two lateral) from the NBM were extracted from anatomically constrained tractography. Structural integrity was compared across controls and cognitive subgroups (PD with normal cognition [PD‐N], with mild cognitive impairment [PD‐MCI], and with dementia [PDD]) and using a continuous global measure of cognition. Results: In PD, we found evidence that lower cognitive performance was associated with increased mean diffusivity across all pathways, especially the perisylvian component of the lateral pathway. In those individuals with dementia, increased free water fraction and decreased fractional anisotropy and fiber density and cross‐section was detected across all pathways. Conclusions: Degeneration of the cortical cholinergic system is associated with cognitive decline in PD. Future work should determine whether pathway degeneration predicts future cognitive decline and dementia. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- 19 October 2026
- Published by Wiley in Movement Disorders
Open AccessCortical Cholinergic Pathway Degeneration Reflects Cognitive Impairment and Dementia in Parkinson's Disease
Background: Cognitive impairment is a prevalent and debilitating feature of Parkinson's disease (PD). Increasing evidence from postmortem and in vivo positron emission tomography imaging studies supports cholinergic dysfunction in PD. There is, however, little evidence regarding the influence of the structural integrity of cortical cholinergic pathways that emanate from the nucleus basalis of Meynert (NBM). Objectives: To investigate the association between cognition and the structural integrity of medial and lateral cortical cholinergic projection pathways in PD. Methods: Neuropsychological assessment, T1 imaging, and high angular resolution diffusion imaging (HARDI) were acquired from 108 participants with PD (41 female, mean age 71.3 years) and 41 control participants (22 female, mean age 70.6 years). Streamlines representing three cortical cholinergic pathways (one medial and two lateral) from the NBM were extracted from anatomically constrained tractography. Structural integrity was compared across controls and cognitive subgroups (PD with normal cognition [PD‐N], with mild cognitive impairment [PD‐MCI], and with dementia [PDD]) and using a continuous global measure of cognition. Results: In PD, we found evidence that lower cognitive performance was associated with increased mean diffusivity across all pathways, especially the perisylvian component of the lateral pathway. In those individuals with dementia, increased free water fraction and decreased fractional anisotropy and fiber density and cross‐section was detected across all pathways. Conclusions: Degeneration of the cortical cholinergic system is associated with cognitive decline in PD. Future work should determine whether pathway degeneration predicts future cognitive decline and dementia. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- Open Access
Source-space EEG functional connectivity and prediction of cognition in Parkinson’s disease: No added benefit of individualized head models over standard templates
Introduction: Cognitive decline is a major non-motor feature of Parkinson’s disease (PD), but reliable and accessible biomarkers remain limited. Resting-state electroencephalography (EEG) is a promising candidate because it is low-cost, portable, and well suited to repeated assessment. Recent work has increasingly focused on source-space functional connectivity (FC) for the prediction of cognition. However, the influence of source modelling based on an individualized MRI-based head model relative to that based on standard template model is unknown. Methods: To compare these two source-space EEG FC methods, we analysed EEG data from the New Zealand Parkinson’s Progression Programme, including 136 people with PD and 51 age-similar controls. Source space resting-state EEG, parcellated with the HCP-MMP1 atlas, was used to derive amplitude envelope correlation (AEC) and debiased weighted phase lag index (dwPLI) across six canonical frequency bands. The resulting twenty-four FC modalities were evaluated using six machine-learning regression algorithms within a nested cross-validation framework. Results: Theta-, alpha-, and beta-band FC showed the most consistent prediction of global cognition. The strongest performance was observed for theta- and alpha-band AEC and dwPLI features (max R² = 0.170, 95% CI = 0.067–0.262; max r = 0.439, 95% CI = 0.328–0.537). Standard and individualized head models showed comparable predictive performance across nearly all modalities. The feature-importance neuroanatomical patterns for Cole-Anticevic networks were also similar between the two head-model options. Conclusions: We found that source-space resting-state EEG FC can predict cognitive performance in PD. The comparability of the two head models suggests that the more user-friendly and less resource-intensive standard template head model is sufficient for this purpose. This supports feasible, scalable, and clinically accessible EEG-based FC biomarkers of cognition in PD.
Open AccessSource-space EEG functional connectivity and prediction of cognition in Parkinson’s disease: No added benefit of individualized head models over standard templates
Introduction: Cognitive decline is a major non-motor feature of Parkinson’s disease (PD), but reliable and accessible biomarkers remain limited. Resting-state electroencephalography (EEG) is a promising candidate because it is low-cost, portable, and well suited to repeated assessment. Recent work has increasingly focused on source-space functional connectivity (FC) for the prediction of cognition. However, the influence of source modelling based on an individualized MRI-based head model relative to that based on standard template model is unknown. Methods: To compare these two source-space EEG FC methods, we analysed EEG data from the New Zealand Parkinson’s Progression Programme, including 136 people with PD and 51 age-similar controls. Source space resting-state EEG, parcellated with the HCP-MMP1 atlas, was used to derive amplitude envelope correlation (AEC) and debiased weighted phase lag index (dwPLI) across six canonical frequency bands. The resulting twenty-four FC modalities were evaluated using six machine-learning regression algorithms within a nested cross-validation framework. Results: Theta-, alpha-, and beta-band FC showed the most consistent prediction of global cognition. The strongest performance was observed for theta- and alpha-band AEC and dwPLI features (max R² = 0.170, 95% CI = 0.067–0.262; max r = 0.439, 95% CI = 0.328–0.537). Standard and individualized head models showed comparable predictive performance across nearly all modalities. The feature-importance neuroanatomical patterns for Cole-Anticevic networks were also similar between the two head-model options. Conclusions: We found that source-space resting-state EEG FC can predict cognitive performance in PD. The comparability of the two head models suggests that the more user-friendly and less resource-intensive standard template head model is sufficient for this purpose. This supports feasible, scalable, and clinically accessible EEG-based FC biomarkers of cognition in PD.
- Open Access
- 17 September 2025
- Published by Elsevier in Neuroimage: Reports
- Vol. 5 (4) , 100289
A transdiagnostic, multi-modal approach to understanding apathy: Methodological and analytical framework
- 17 September 2025
- Published by Elsevier in Neuroimage: Reports
- Vol. 5 (4) , 100289
Open AccessA transdiagnostic, multi-modal approach to understanding apathy: Methodological and analytical framework
- Open Access
- 11 July 2025
- Published by SAGE Publications in Dementia
- Vol. 25 (5) , 1159-1187
A Systematic Review of Communication-Focused Dementia Interventions for Indigenous Communities
Dementia is a significant challenge for many Indigenous peoples who face inequities in risk factors, prevalence, progression rates, and access to quality healthcare. Culturally relevant interventions are needed across the care pathway, however, little evidence exists to guide culturally relevant communication support. This systematic review aims to understand dementia communication interventions developed for Indigenous populations and explore factors relating to their effectiveness. A systematic search of databases, repositories, and search engines was conducted. We took a comprehensive approach to communication, considering the communication skills and abilities of people with dementia, their communication partners, healthcare providers, and community-level information sharing. Studies were required to evaluate an intervention targeting communicative skills, communicative ability, or health communication and include a cultural focus on one or more Indigenous communities. Quality was appraised using an adapted Well Living House Quality Appraisal Tool. Six studies met inclusion criteria, with most studies ( n = 5) conducted from 2019 onwards. No studies evaluated an intervention targeting communicative skills and abilities for people with dementia, their communication partners, or healthcare providers. All included studies evaluated a health communication intervention. Interventions utilised various resources, including storybooks, videos, flipcharts, posters, handouts, worksheets, fact sheets, and training modules, tailored towards Indigenous communities across Canada, the United States, and Australia. Content about dementia and dementia management varied across interventions. Analysis identified key benefits of the interventions and three factors influencing their effectiveness: (1) representation of Indigenous people, cultures, and languages in resources, (2) methods and settings for knowledge sharing, and (3) communication, connection, and collaboration. While content within resources and methods for information sharing should be tailored to local communities, common elements may support health communication developments across Indigenous contexts. Further research is needed to develop interventions specifically targeting communication skills and conduct methodologically strong evaluations.
- 11 July 2025
- Published by SAGE Publications in Dementia
- Vol. 25 (5) , 1159-1187
Open AccessA Systematic Review of Communication-Focused Dementia Interventions for Indigenous Communities
Dementia is a significant challenge for many Indigenous peoples who face inequities in risk factors, prevalence, progression rates, and access to quality healthcare. Culturally relevant interventions are needed across the care pathway, however, little evidence exists to guide culturally relevant communication support. This systematic review aims to understand dementia communication interventions developed for Indigenous populations and explore factors relating to their effectiveness. A systematic search of databases, repositories, and search engines was conducted. We took a comprehensive approach to communication, considering the communication skills and abilities of people with dementia, their communication partners, healthcare providers, and community-level information sharing. Studies were required to evaluate an intervention targeting communicative skills, communicative ability, or health communication and include a cultural focus on one or more Indigenous communities. Quality was appraised using an adapted Well Living House Quality Appraisal Tool. Six studies met inclusion criteria, with most studies ( n = 5) conducted from 2019 onwards. No studies evaluated an intervention targeting communicative skills and abilities for people with dementia, their communication partners, or healthcare providers. All included studies evaluated a health communication intervention. Interventions utilised various resources, including storybooks, videos, flipcharts, posters, handouts, worksheets, fact sheets, and training modules, tailored towards Indigenous communities across Canada, the United States, and Australia. Content about dementia and dementia management varied across interventions. Analysis identified key benefits of the interventions and three factors influencing their effectiveness: (1) representation of Indigenous people, cultures, and languages in resources, (2) methods and settings for knowledge sharing, and (3) communication, connection, and collaboration. While content within resources and methods for information sharing should be tailored to local communities, common elements may support health communication developments across Indigenous contexts. Further research is needed to develop interventions specifically targeting communication skills and conduct methodologically strong evaluations.
- 26 March 2025
- Published by Elsevier in Trends in Neurosciences
- Vol. 48 (4) , 297-311
Understanding disrupted motivation in Parkinson’s disease through a value-based decision-making lens
- 26 March 2025
- Published by Elsevier in Trends in Neurosciences
- Vol. 48 (4) , 297-311
Understanding disrupted motivation in Parkinson’s disease through a value-based decision-making lens
- 11 March 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (5) , e209958
Author Response: Cross-Sectional and Longitudinal Association of Clinical and Neurocognitive Factors With Apathy in Patients With Parkinson Disease
- 11 March 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (5) , e209958
Author Response: Cross-Sectional and Longitudinal Association of Clinical and Neurocognitive Factors With Apathy in Patients With Parkinson Disease
- Open Access
- 6 December 2024
- Published by Walter de Gruyter GmbH in Timing & Time Perception
- Vol. -1 (aop) , 1-24
Disrupted Time Perception Underlies Motivational Disturbances in Huntington’s Disease
Our sense of time is fundamental to interacting with the world in a goal-directed manner, with decisions underpinning goal pursuit utilising timing circuits in the seconds-to-minutes range. A reduction in goal-directed behaviour — apathy — is common in Huntington’s disease (HD), but no work has examined whether altered time perception could be a contributing mechanism. We investigated whether timing deficits were evident in HD apathy. Genetically confirmed carriers of the HD mutation (premanifest to mild manifest disease, n = 39) and healthy controls ( n = 20) performed a time production task with active (press) and passive (wait) modes of production, alongside clinical and behavioural measures. Overall, people with HD underproduced target times whilst controls performed in near-optimal manner. In HD, there were significant interactions between condition ( press / wait ) and both apathy and impulsivity (apathy × condition: t = −3.8, p = 0.0002; impulsivity × condition: t = −3.3, p = 0.001). This was driven by people with either of these behavioural disturbances producing shorter times in the passive condition, relative to people without these behaviours. Whilst global timing deficits were evident in HD, further differences were evident as a function of apathy and impulsivity, whereby people thought more time had passed than really had, specifically when passively waiting . Altered time perception when passively waiting may alter estimation of environmental reward rates and subsequent decisions of when to act. Overall, and demonstrated in human neurological disease, we show that timing processes and motivated behaviours are fundamentally linked.
- 6 December 2024
- Published by Walter de Gruyter GmbH in Timing & Time Perception
- Vol. -1 (aop) , 1-24
Open AccessDisrupted Time Perception Underlies Motivational Disturbances in Huntington’s Disease
Our sense of time is fundamental to interacting with the world in a goal-directed manner, with decisions underpinning goal pursuit utilising timing circuits in the seconds-to-minutes range. A reduction in goal-directed behaviour — apathy — is common in Huntington’s disease (HD), but no work has examined whether altered time perception could be a contributing mechanism. We investigated whether timing deficits were evident in HD apathy. Genetically confirmed carriers of the HD mutation (premanifest to mild manifest disease, n = 39) and healthy controls ( n = 20) performed a time production task with active (press) and passive (wait) modes of production, alongside clinical and behavioural measures. Overall, people with HD underproduced target times whilst controls performed in near-optimal manner. In HD, there were significant interactions between condition ( press / wait ) and both apathy and impulsivity (apathy × condition: t = −3.8, p = 0.0002; impulsivity × condition: t = −3.3, p = 0.001). This was driven by people with either of these behavioural disturbances producing shorter times in the passive condition, relative to people without these behaviours. Whilst global timing deficits were evident in HD, further differences were evident as a function of apathy and impulsivity, whereby people thought more time had passed than really had, specifically when passively waiting . Altered time perception when passively waiting may alter estimation of environmental reward rates and subsequent decisions of when to act. Overall, and demonstrated in human neurological disease, we show that timing processes and motivated behaviours are fundamentally linked.
- Open Access
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S2)
Early phase Amyloid‐PET reproduces metabolic signatures of cognitive decline in Parkinson's disease
Background: Establishing practical and effective diagnostic pathways for people with cognitive impairment is a crucial international research priority. Traditional (late‐phase) analysis of an amyloid‐beta (Aβ) PET scan (∼90 minutes after radiotracer injection) provides important information about the presence/absence of underlying Alzheimer’s pathology, but no information about brain metabolism/perfusion. Recent work suggests that amyloid‐beta PET tracer uptake shortly after injection (‘early‐phase’) closely reflects brain metabolism and perfusion. Parkinson’s disease (PD), the second most common neurodegenerative disease worldwide, serves as a model disorder in which cognitive impairment occurs across a spectrum, is not specifically associated with underlying brain amyloid status, and has known patterns of altered metabolism and perfusion associated with cognitive decline. We investigated the utility of early‐phase 18F‐Florbetaben Aβ PET (eFBB) uptake as a surrogate marker of cerebral perfusion/metabolism in people with PD. We hypothesised that eFBB uptake would reproduce characteristic patterns of hypometabolism and hypoperfusion associated with cognitive decline in PD, irrespective of late‐phase Aβ status, and positively correlate with a direct measure of cerebral perfusion – ASL MRI.Method: 115 closely phenotyped PD patients across the spectrum of cognitive impairment underwent dual‐phase (early and late) Aβ PET, structural and perfusion (ASL) MRI, and neuropsychological assessments. Multiple linear regression models compared eFBB uptake with 1) cognitive performance and 2) ASL‐MRI perfusion, correcting for multiple comparisons by family‐wise error correction (threshold‐free cluster enhancement).Result: eFBB uptake significantly correlated with cerebral perfusion across widespread cortical and subcortical regions (r = 0.15‐0.49, p < 0.005, Figure 2). Reduced eFBB uptake was significantly associated with poorer cognitive performance in brain regions previously linked to hypometabolism‐associated cognitive decline in PD: parieto‐occipital regions, middle and inferior temporal gyri, prefrontal cortex and the thalamus (all p < 0.05, Figure 1). These findings were independent of amyloid status.Conclusion: eFBB uptake is a reliable surrogate measure for cerebral perfusion/metabolism in a predominantly Aβ negative group. It provides complimentary information to the late‐phase Aβ scan, and can add value whether the late phase is positive or negative. Such dual‐phase PET imaging approaches show significant promise in streamlining diagnostic pathways for people with cognitive impairment.
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S2)
Open AccessEarly phase Amyloid‐PET reproduces metabolic signatures of cognitive decline in Parkinson's disease
Background: Establishing practical and effective diagnostic pathways for people with cognitive impairment is a crucial international research priority. Traditional (late‐phase) analysis of an amyloid‐beta (Aβ) PET scan (∼90 minutes after radiotracer injection) provides important information about the presence/absence of underlying Alzheimer’s pathology, but no information about brain metabolism/perfusion. Recent work suggests that amyloid‐beta PET tracer uptake shortly after injection (‘early‐phase’) closely reflects brain metabolism and perfusion. Parkinson’s disease (PD), the second most common neurodegenerative disease worldwide, serves as a model disorder in which cognitive impairment occurs across a spectrum, is not specifically associated with underlying brain amyloid status, and has known patterns of altered metabolism and perfusion associated with cognitive decline. We investigated the utility of early‐phase 18F‐Florbetaben Aβ PET (eFBB) uptake as a surrogate marker of cerebral perfusion/metabolism in people with PD. We hypothesised that eFBB uptake would reproduce characteristic patterns of hypometabolism and hypoperfusion associated with cognitive decline in PD, irrespective of late‐phase Aβ status, and positively correlate with a direct measure of cerebral perfusion – ASL MRI.Method: 115 closely phenotyped PD patients across the spectrum of cognitive impairment underwent dual‐phase (early and late) Aβ PET, structural and perfusion (ASL) MRI, and neuropsychological assessments. Multiple linear regression models compared eFBB uptake with 1) cognitive performance and 2) ASL‐MRI perfusion, correcting for multiple comparisons by family‐wise error correction (threshold‐free cluster enhancement).Result: eFBB uptake significantly correlated with cerebral perfusion across widespread cortical and subcortical regions (r = 0.15‐0.49, p < 0.005, Figure 2). Reduced eFBB uptake was significantly associated with poorer cognitive performance in brain regions previously linked to hypometabolism‐associated cognitive decline in PD: parieto‐occipital regions, middle and inferior temporal gyri, prefrontal cortex and the thalamus (all p < 0.05, Figure 1). These findings were independent of amyloid status.Conclusion: eFBB uptake is a reliable surrogate measure for cerebral perfusion/metabolism in a predominantly Aβ negative group. It provides complimentary information to the late‐phase Aβ scan, and can add value whether the late phase is positive or negative. Such dual‐phase PET imaging approaches show significant promise in streamlining diagnostic pathways for people with cognitive impairment.
- 25 June 2024
- Published by Wolters Kluwer Health in Neurology
- Vol. 102 (12) , e209301
Cross-Sectional and Longitudinal Association of Clinical and Neurocognitive Factors With Apathy in Patients With Parkinson Disease
A robust understanding of the natural history of apathy in Parkinson disease (PD) is foundational for developing effective clinical management tools. However, large longitudinal studies are lacking while the literature is inconsistent about even cross-sectional associations. We aimed to determine the longitudinal predictors of apathy development in a large cohort of people with PD and its cross-sectional associations and trajectories over time, using sophisticated Bayesian modeling techniques. People with PD followed up in the longitudinal New Zealand Parkinson's progression project were included. Apathy was defined using the neuropsychiatric inventory subscale ≥4, and analyses were also repeated using a less stringent cutoff of ≥1. Both MoCA and comprehensive neuropsychological testing were used as appropriate to the model. Depression was assessed using the hospital anxiety and depression scale. Cross-sectional Bayesian regressions were conducted, and a multistate predictive model was used to identify factors that predict the initial onset of apathy in nonapathetic PD, while also accounting for the competing risk of death. The relationship between apathy presence and mortality was also investigated. Three hundred forty-six people with PD followed up for up to 14 years across a total of 1,392 sessions were included. Apathy occurrence did not vary significantly across the disease course (disease duration odds ratio [OR] = 0.55, [95% CI 0.28-1.12], affecting approximately 11% or 22% of people at any time depending on the NPI cutoff used. Its presence was associated with a significantly higher risk of death after controlling for all other factors (hazard ratio [HR] = 2.92 [1.50-5.66]). Lower cognition, higher depression levels, and greater motor severity predicted apathy development in those without motivational deficits (HR [cognition] = 0.66 [0.48-0.90], HR [depression] = 1.45 [1.04-2.02], HR [motor severity] = 1.37 [1.01-1.86]). Cognition and depression were also associated with apathy cross-sectionally, along with male sex and possibly lower dopaminergic therapy level, but apathy still occurred across the full spectrum of each variable (OR [cognition] = 0.58 [0.44-0.76], OR [depression] = 1.43 [1.04-1.97], OR [female sex] = 0.45 [0.22-0.92], and OR [levodopa equivalent dose] = 0.78 [0.59-1.04]. Apathy occurs across the PD time course and is associated with higher mortality. Depressive symptoms and cognitive impairment in particular predict its future development in those with normal motivation.
- 25 June 2024
- Published by Wolters Kluwer Health in Neurology
- Vol. 102 (12) , e209301
Cross-Sectional and Longitudinal Association of Clinical and Neurocognitive Factors With Apathy in Patients With Parkinson Disease
A robust understanding of the natural history of apathy in Parkinson disease (PD) is foundational for developing effective clinical management tools. However, large longitudinal studies are lacking while the literature is inconsistent about even cross-sectional associations. We aimed to determine the longitudinal predictors of apathy development in a large cohort of people with PD and its cross-sectional associations and trajectories over time, using sophisticated Bayesian modeling techniques. People with PD followed up in the longitudinal New Zealand Parkinson's progression project were included. Apathy was defined using the neuropsychiatric inventory subscale ≥4, and analyses were also repeated using a less stringent cutoff of ≥1. Both MoCA and comprehensive neuropsychological testing were used as appropriate to the model. Depression was assessed using the hospital anxiety and depression scale. Cross-sectional Bayesian regressions were conducted, and a multistate predictive model was used to identify factors that predict the initial onset of apathy in nonapathetic PD, while also accounting for the competing risk of death. The relationship between apathy presence and mortality was also investigated. Three hundred forty-six people with PD followed up for up to 14 years across a total of 1,392 sessions were included. Apathy occurrence did not vary significantly across the disease course (disease duration odds ratio [OR] = 0.55, [95% CI 0.28-1.12], affecting approximately 11% or 22% of people at any time depending on the NPI cutoff used. Its presence was associated with a significantly higher risk of death after controlling for all other factors (hazard ratio [HR] = 2.92 [1.50-5.66]). Lower cognition, higher depression levels, and greater motor severity predicted apathy development in those without motivational deficits (HR [cognition] = 0.66 [0.48-0.90], HR [depression] = 1.45 [1.04-2.02], HR [motor severity] = 1.37 [1.01-1.86]). Cognition and depression were also associated with apathy cross-sectionally, along with male sex and possibly lower dopaminergic therapy level, but apathy still occurred across the full spectrum of each variable (OR [cognition] = 0.58 [0.44-0.76], OR [depression] = 1.43 [1.04-1.97], OR [female sex] = 0.45 [0.22-0.92], and OR [levodopa equivalent dose] = 0.78 [0.59-1.04]. Apathy occurs across the PD time course and is associated with higher mortality. Depressive symptoms and cognitive impairment in particular predict its future development in those with normal motivation.
- Open Access
- 26 March 2024
- Published by Oxford University Press (OUP) in Brain
- Vol. 147 (4) , 1127-1129
Learning the value of experience
This scientific commentary refers to ‘Impaired value-based decision-making in Parkinson’s disease apathy’ by Gilmour et al. (https://doi.org/10.1093/brain/awae025).
- 26 March 2024
- Published by Oxford University Press (OUP) in Brain
- Vol. 147 (4) , 1127-1129
Open AccessLearning the value of experience
This scientific commentary refers to ‘Impaired value-based decision-making in Parkinson’s disease apathy’ by Gilmour et al. (https://doi.org/10.1093/brain/awae025).